401. Pneumocystis jirovecii Pneumonia in Renal Transplant Recipients After a 6-Month Trimethoprim–Sulfamethoxazole Prophylaxis: A Case–Control Study

BACKGROUND: Pneumocystis jiroveci pneumonia (PCP) is an important cause of morbidity and mortality in kidney transplant recipients (KTRs). Chemoprophylaxis with trimethoprim-sulfamethoxazole (TMP-SMX) is recommended about 6–12 months after solid-organ transplantation. However, PCP occasionally occur...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Se Yoon, Shin, Sung, Kim, Young-Hoon, Jung, Joo Hee, Kim, Sung-Han, Han, Duck Jong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253466/
http://dx.doi.org/10.1093/ofid/ofy210.412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253466/
http://dx.doi.org/10.1093/ofid/ofy210.412

Ejemplares similares